Stephen Willard

Insider Reports History

Entity
Individual
Location
1201 Orange Street, Suite 600, Wilmington, DE
Signature
/s/ Stephen Willard
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Willard:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NRX Pharmaceuticals, Inc. CHIEF EXECUTIVE OFFICER, Director Common Stock, par value $0.001 per share 50K $16K $0.32 Dec 16, 2022 Direct

Insider Reports Filed by Stephen Willard

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NRXP NRX Pharmaceuticals, Inc. Dec 16, 2022 1 $58.5K 4 Dec 19, 2022 CHIEF EXECUTIVE OFFICER, Director
NRXP NRX Pharmaceuticals, Inc. Jul 12, 2022 0 $0 3 Jul 22, 2022 Chief Executive Officer, Director